Skip to main content
. 2020 Mar 30;12(4):828. doi: 10.3390/cancers12040828
BRCA1 Breast cancer type 1 susceptibility protein
CK 5/6 Cytokeratin 5/6
CT Chemotherapy
DNA Deoxyribonucleic acid
EGFR Epidermal growth factor receptor
ER Estrogen receptor
HER2 Human epidermal growth factor receptor 2
IHC Immunohistochemistry
MS-PCR Methylation-specific polymerase chain reaction
OS Overall survival
PARP-1 Poly(ADP-ribose) polymerase 1
PARPi PARP inhibitor
PCR Polymerase chain reaction
PR Progesterone receptor
RFS Relapse-free survival
RNA Ribonucleic acid
TMA Tissue microarray
TNBC Triple-negative breast cancer